Close

Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Analyst Day Takeaways Dec 5, 2011 08:43AM
Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); FDA Will Not Sanction Cabo CRPC Strategy Nov 1, 2011 08:24AM
Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Cabo 306 Trial Should Start Before Year End Oct 28, 2011 09:54AM
Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Cautious Ahead of Cabo P3 MTC Data Sep 28, 2011 08:38AM
Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Improved Visibility on Cabo CRPC Registration Path Jun 7, 2011 08:50AM


Jun 6, 2011 01:26PM Unusual 11 Mid-Day Movers 06/06: (ADES) (ZN) (COOL) Higher; (EXEL) (SNSS) (BAP) Lower
Jun 6, 2011 09:12AM Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); New Cabo Data Could Complicate FDA Strategy; Remain Cautious
May 19, 2011 11:11AM Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Sutent Phase III CRPC Data Portends Cabo Risks
May 10, 2011 11:21AM Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Q1 Update; Clarity on Cabo Filing Strategy Soon
Apr 26, 2011 10:59AM Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); High Stock Impact Expected on Cabo MTC Trial Outcome
Feb 22, 2011 11:30AM Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); High Cabo Regulatory Risk Despite Validated Activity
Dec 28, 2010 09:35AM Canaccord Genuity on Life Sciences/Biotechnology: Selected Small Cap Biotech Roundup
Dec 3, 2010 11:16AM Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Singular focus on XL184 For Prostate Cancer